ClinicalTrials.govpublic full text
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)
facioscapulohumeral muscular dystrophy (fshd), facioscapulohumeral muscular dystrophy type 1 (fshd 1), facioscapulohumeral muscular dystrophy type 2 (fshd 2), muscular dystrophy, facioscapulohumeral muscular disorders, musculoskeletal diseases, neuromuscular diseases, reach, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 875093
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.